Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

Lenard A. Adler, David W. Goodman, Scott H. Kollins, Richard H. Weisler, Suma Krishnan, Yuxin Zhang, Joseph Biederman

Research output: Contribution to journal › Article › peer-review

168 Scopus citations

Fingerprint

Dive into the research topics of 'Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences